Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC score

Abstract Background Lung cancer (LC) causes more deaths worldwide than any other cancer type. Despite advances in therapeutic strategies, the fatality rate of LC cases remains high (95%) since the majority of patients are diagnosed at late stages when patient prognosis is poor. Analysis of the Inter...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Karla Rubio, Jason M. Müller, Aditi Mehta, Iris Watermann, Till Olchers, Ina Koch, Sabine Wessels, Marc A. Schneider, Tania Araujo-Ramos, Indrabahadur Singh, Christian Kugler, Mircea Gabriel Stoleriu, Mark Kriegsmann, Martin Eichhorn, Thomas Muley, Olivia M. Merkel, Thomas Braun, Ole Ammerpohl, Martin Reck, Achim Tresch, Guillermo Barreto
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer 2023-10-01
Serija:	Discover Oncology
Teme:	Lung cancer Biomarker Diagnostic Exhaled breath condensate GATA6 NKX2-1
Online dostop:	https://doi.org/10.1007/s12672-023-00799-9
Oznake:	Označite Brez oznak, prvi označite!